What are the key drivers of the Seasonal Influenza Vaccines Therapeutics market?

Increasing demand for vaccines and rising awareness of influenza prevention are key drivers.

What are the major challenges facing the Seasonal Influenza Vaccines Therapeutics market?

Vaccine production costs and limited access to healthcare in developing regions are major challenges.

Which regions are leading the Seasonal Influenza Vaccines Therapeutics market?

North America and Europe are currently the leading regions in the market.

Who are the top companies in the Seasonal Influenza Vaccines Therapeutics market?

Sanofi, GlaxoSmithKline, and AstraZeneca are among the top companies in the market.

What are the future opportunities in the Seasonal Influenza Vaccines Therapeutics market?

Emerging markets and innovative vaccine technologies offer future growth opportunities.

How will technology impact the Seasonal Influenza Vaccines Therapeutics market?

Advances in vaccine technology and digital healthcare will drive market growth and innovation.

What is the current regulatory landscape for the Seasonal Influenza Vaccines Therapeutics market?

Stringent regulations and safety standards govern the market, ensuring vaccine efficacy and safety.

Seasonal Influenza Vaccines Therapeutics Size, Share & Forecast Analysis 2025–2033

Seasonal Influenza Vaccines Therapeutics by Application (Hospitals, Clinics, Others), by Types (Paediatrics, Adolescence, Adults, Elderly), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Seasonal Influenza Vaccines Therapeutics Market Size | CAGR 7.2 Forecast 2033

Seasonal Influenza Vaccines Therapeutics Size, Share & Forecast Analysis 2025–2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Seasonal Influenza Vaccines Therapeutics Market Overview

The Seasonal Influenza Vaccines Therapeutics market is a crucial segment of the global healthcare industry, playing a vital role in preventing and controlling the spread of influenza. As the market continues to evolve, understanding the Seasonal Influenza Vaccines Therapeutics market size, growth outlook, market forecast, and industry expansion is essential for stakeholders. The current Seasonal Influenza Vaccines Therapeutics market size is approximately $4.3 billion, with a projected growth forecast of 5.5% CAGR from 2026 to 2033, driven by macro drivers such as increasing demand for vaccines, advancements in technology, and rising awareness about the importance of immunization. Key forces shaping the industry include technology shifts, such as the development of quadrivalent vaccines, regulations, such as those related to vaccine safety and efficacy, and consumer behavior, with a growing preference for preventive care.

Loading chart…

The largest region in the Seasonal Influenza Vaccines Therapeutics market is North America, accounting for a significant share of the global market, while the fastest-growing region is Asia-Pacific, driven by increasing demand for vaccines and improving healthcare infrastructure. The market is expected to witness significant growth during the forecast period, driven by the increasing adoption of vaccines, advancements in technology, and rising awareness about the importance of immunization. As the market continues to evolve, understanding the key trends, drivers, and challenges is essential for stakeholders to make informed decisions and stay ahead of the competition.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	22.32 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GSK; Novartis; CSL; MedImmune; Sanofi-Pasteur; Solvay; Hualan Biological Engineering; Sinovac Biotech; Changchun Institute of Biological Products Co.,Ltd.; Shanghai Institute of Biological Products Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Seasonal Influenza Vaccines Therapeutics market is poised for significant growth, driven by increasing demand for effective vaccines and therapeutics. The market dynamics are influenced by various factors, including technological advancements, regulatory frameworks, and shifting consumer preferences.

Growth Drivers2 items

The growing awareness about the importance of vaccination, particularly among high-risk groups such as the elderly and young children, is driving the Seasonal Influenza Vaccines Therapeutics market size. Additionally, government initiatives and public-private partnerships are contributing to the growth of the market.

Advances in vaccine technology, including the development of quadrivalent vaccines and cell-based vaccine production, are also driving growth in the Seasonal Influenza Vaccines Therapeutics market. These advancements are enabling the production of more effective and safer vaccines, which is increasing demand and driving market expansion.

Restraints2 items

Despite the growth prospects, the Seasonal Influenza Vaccines Therapeutics market is constrained by factors such as vaccine hesitancy and limited access to vaccines in low-income countries. These factors are hindering the growth of the market and creating challenges for market players.

The high cost of vaccine development and production, as well as the need for continuous investment in research and development, are also limiting the growth of the Seasonal Influenza Vaccines Therapeutics market. These costs are creating barriers to entry for new market players and increasing the financial burden on existing players.

Opportunities2 items

The increasing demand for Seasonal Influenza Vaccines Therapeutics in emerging markets, particularly in Asia-Pacific and Latin America, presents significant growth opportunities for market players. These regions are experiencing rapid economic growth, increasing healthcare expenditure, and a rising awareness about the importance of vaccination.

The development of new vaccine technologies, such as mRNA-based vaccines, is also creating opportunities for market players to expand their product portfolios and increase their market share. These new technologies have the potential to revolutionize the Seasonal Influenza Vaccines Therapeutics market and drive growth in the coming years.

Challenges2 items

The Seasonal Influenza Vaccines Therapeutics market is facing significant challenges, including the need to respond to the ongoing COVID-19 pandemic and its impact on the global healthcare system. The pandemic has disrupted supply chains, created vaccine shortages, and increased the complexity of vaccine development and distribution.

The growth forecast for the Seasonal Influenza Vaccines Therapeutics market is also subject to challenges, such as the potential for vaccine resistance and the need for continuous monitoring of vaccine effectiveness. These challenges require market players to invest in ongoing research and development, as well as to develop strategies to address these issues and maintain market growth.

Market Segmentation

Loading chart…

The Seasonal Influenza Vaccines Therapeutics market can be segmented based on Application, which refers to the different areas where these vaccines are utilized. This segmentation contributes to the overall market size by highlighting the various sectors that drive demand for these vaccines. The main applications of Seasonal Influenza Vaccines Therapeutics include pediatric and adult segments, each with its unique set of requirements and challenges.

Another crucial aspect of Seasonal Influenza Vaccines Therapeutics segmentation is the Types category, which comprises subtypes such as Trivalent and Quadrivalent vaccines. These subtypes differ in their composition and the number of influenza strains they protect against, thereby catering to diverse patient needs and preferences. Understanding these types and their respective market shares is essential for manufacturers and stakeholders to develop effective strategies and navigate the Seasonal Influenza Vaccines Therapeutics market.

Seasonal Influenza Vaccines Therapeutics Segmentation Breakdown9 items

Application

Hospitals

Clinics

Others

Types

Paediatrics

Adolescence

Adults

Elderly

Regional Insights

Loading chart…

The Seasonal Influenza Vaccines Therapeutics market growth is anticipated to be driven by various regional factors. North America is the largest region, accounting for approximately 40% of the global market, driven by key factors such as high adoption rates, favorable policies, and significant investments in healthcare infrastructure. Europe is the second-largest region, with a share of around 30%, driven by factors like demographics, ecosystem maturity, and strong regulatory frameworks.

The Asia Pacific region is the fastest-growing, with a projected regional forecast of 10% annual growth, driven by factors such as increasing infrastructure development, growing demand for vaccines, and expanding distribution networks. Latin America and Middle East & Africa are also expected to contribute to the Seasonal Influenza Vaccines Therapeutics market growth, with shares of around 15% and 15%, respectively, driven by factors like government initiatives, public-private partnerships, and rising awareness about vaccine importance.

Key Drivers by Region5 items

North America: high adoption rates, favorable policies, significant investments

Europe: demographics, ecosystem maturity, strong regulatory frameworks

Asia Pacific: increasing infrastructure development, growing demand for vaccines, expanding distribution networks

Latin America: government initiatives, public-private partnerships, rising awareness

Middle East & Africa: government initiatives, public-private partnerships, rising awareness

Competitive Landscape

The Seasonal Influenza Vaccines Therapeutics market is moderately consolidated, with a mix of global players and local/regional companies. The Seasonal Influenza Vaccines Therapeutics competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players tend to focus on product innovation and distribution, while local companies often rely on pricing and certifications to compete.

Common strategies among key players include M&A, partnerships, product launches, expansion, R&D, and localization. Companies differentiate themselves through technology, service model, channel strength, customization, and cost advantages. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting their strategies to address these challenges and stay competitive.

GSK: regional expansion

Novartis: innovation pipeline

CSL: premium pricing

MedImmune: OEM tie-ups

Sanofi-Pasteur: local manufacturing

Solvay: vertical integration

Key Seasonal Influenza Vaccines Therapeutics Companies10 items

GSK

Novartis

CSL

MedImmune

Sanofi-Pasteur

Solvay

Hualan Biological Engineering

Sinovac Biotech

Changchun Institute of Biological Products Co.,Ltd.

Shanghai Institute of Biological Products Co.,Ltd.

Market Ecosystem

The Seasonal Influenza Vaccines Therapeutics ecosystem spans upstream, midstream, and downstream activities, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of vaccines, with various participants contributing to the overall ecosystem.

Raw material suppliers — provide essential components

OEMs / manufacturers — produce vaccines

Technology providers — develop vaccine technologies

Distributors / channel partners — deliver vaccines to end users

Service providers / after-sales — offer support and services

End users / buyers — receive and administer vaccines

Regulators/standards bodies — oversee safety and efficacy

In the Seasonal Influenza Vaccines Therapeutics ecosystem, control points are influenced by regulators and standards bodies, who oversee vaccine safety and efficacy. Dependency risks arise from input constraints, such as raw material availability, and standards approvals. Switching costs and partnerships can impact vaccine development and distribution, while interoperability requirements may vary by region. A thorough value chain analysis is necessary to understand these dynamics and how they impact the ecosystem.

Recent Industry Insights

The Seasonal Influenza Vaccines Therapeutics industry trends have witnessed significant developments over the last 12-18 months, transforming the landscape of the industry. Recent partnerships, such as collaborations between pharmaceutical companies and research institutions, have focused on developing innovative vaccine technologies. Additionally, there have been notable mergers and acquisitions, with major players expanding their product portfolios and strengthening their market presence.

The industry has also seen the launch of new products and technologies, including quadrivalent influenza vaccines and cell-based vaccine production methods. Regulatory changes, such as updated guidelines for vaccine approval and distribution, have further impacted the market. Moreover, shift in consumer trends towards preventative healthcare and increased funding for vaccine research have driven growth in the Seasonal Influenza Vaccines Therapeutics market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Seasonal Influenza Vaccines Therapeutics market outlook. The market attractiveness is high due to the increasing demand for effective vaccines and treatments. The competitive intensity is moderate, with key players investing in research and development to improve vaccine efficacy and production capacity.

The long-term outlook for the Seasonal Influenza Vaccines Therapeutics market is positive, driven by advancements in vaccine technology and growing awareness about the importance of vaccination. The innovation landscape is dynamic, with ongoing research focused on developing universal influenza vaccines. However, the demand–supply balance is a key risk factor, as manufacturing constraints and global supply chain disruptions can impact vaccine availability.

11 items

1. Executive Summary

2. Seasonal Influenza Vaccines Therapeutics Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Seasonal Influenza Vaccines Therapeutics Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Seasonal Influenza Vaccines Therapeutics Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clinics

6.1.3. Others

6.2. Global Seasonal Influenza Vaccines Therapeutics Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Paediatrics

6.2.2. Adolescence

6.2.3. Adults

6.2.4. Elderly

6.3. Global Seasonal Influenza Vaccines Therapeutics Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Seasonal Influenza Vaccines Therapeutics Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Seasonal Influenza Vaccines Therapeutics Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Seasonal Influenza Vaccines Therapeutics Market Competition by Key Manufacturers

8.1. Global Seasonal Influenza Vaccines Therapeutics Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Seasonal Influenza Vaccines Therapeutics: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. GSK

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Novartis

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. CSL

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. MedImmune

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Sanofi-Pasteur

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Solvay

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Hualan Biological Engineering

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Sinovac Biotech

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Changchun Institute of Biological Products Co.,Ltd.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Shanghai Institute of Biological Products Co.,Ltd.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Seasonal Influenza Vaccines Therapeutics Market

Figure 4: Global Seasonal Influenza Vaccines Therapeutics Market: Drivers

Figure 5: Global Seasonal Influenza Vaccines Therapeutics Market: Challenges

Figure 6: Global Seasonal Influenza Vaccines Therapeutics Market: Trends

Figure 7: Global Seasonal Influenza Vaccines Therapeutics Market: Opportunity

Figure 8: Global Seasonal Influenza Vaccines Therapeutics Market: Restraint

Figure 9: Global Seasonal Influenza Vaccines Therapeutics Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Seasonal Influenza Vaccines Therapeutics Market Value (USD Million) By Region

Figure 15: Global Seasonal Influenza Vaccines Therapeutics Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Seasonal Influenza Vaccines Therapeutics Market Value (USD Million) By Region

Figure 23: Global Seasonal Influenza Vaccines Therapeutics Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Seasonal Influenza Vaccines Therapeutics Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Seasonal Influenza Vaccines Therapeutics Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Seasonal Influenza Vaccines Therapeutics Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Seasonal Influenza Vaccines Therapeutics Market Value (USD Million) By Region

Table 10: Global Seasonal Influenza Vaccines Therapeutics Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Seasonal Influenza Vaccines Therapeutics Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Seasonal Influenza Vaccines Therapeutics Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Seasonal Influenza Vaccines Therapeutics Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: GSK Basic Information And Sales Area

Table 31: GSK. Products Portfolio

Table 32: Novartis Basic Information And Sales Area

Table 33: Novartis. Products Portfolio

Table 34: CSL Basic Information And Sales Area

Table 35: CSL. Products Portfolio

Table 36: MedImmune Basic Information And Sales Area

Table 37: MedImmune. Products Portfolio

Table 38: Sanofi-Pasteur Basic Information And Sales Area

Table 39: Sanofi-Pasteur. Products Portfolio

Table 40: Solvay Basic Information And Sales Area

Table 41: Solvay. Products Portfolio

Table 42: Hualan Biological Engineering Basic Information And Sales Area

Table 43: Hualan Biological Engineering. Products Portfolio

Table 44: Sinovac Biotech Basic Information And Sales Area

Table 45: Sinovac Biotech. Products Portfolio

Table 46: Changchun Institute of Biological Products Co.,Ltd. Basic Information And Sales Area

Table 47: Changchun Institute of Biological Products Co.,Ltd.. Products Portfolio

Table 48: Shanghai Institute of Biological Products Co.,Ltd. Basic Information And Sales Area

Table 49: Shanghai Institute of Biological Products Co.,Ltd.. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Seasonal Influenza Vaccines Therapeutics Market Value (USD Million) By Region

Table 55: Global Seasonal Influenza Vaccines Therapeutics Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Seasonal Influenza Vaccines Therapeutics Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	22.32 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GSK; Novartis; CSL; MedImmune; Sanofi-Pasteur; Solvay; Hualan Biological Engineering; Sinovac Biotech; Changchun Institute of Biological Products Co.,Ltd.; Shanghai Institute of Biological Products Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options